|
(b)(4).This is a combination product, and the event has been reviewed for both the suture and the triclosan.A manufacturing record evaluation was performed for the finished device pj4119 and no non conformance's/ manufacturing irregularities related to the malfunction were identified investigation summary: the product was returned for evaluation.Visual inspection evaluation was conducted on the returned device.Visual analysis of the returned sample determined that a sealed sample of product code vcp726 was received for evaluation.Visual inspection of the unopened sample was performed, and damaged on the foil packet could be observed.The damaged was caused apparently with a sharp object from outside to inside the packet.As part of our quality process, the manufacturing records of this lot-serial number were reviewed, and the manufacturing standards were met prior to the release of this batch.No conclusion could be reached as to what caused the reported complaint.It should be noted that as part of our quality process, each batch is randomly inspected and functionally tested during manufacturing to ensure the device meets the required specifications prior to shipment.Additional information was requested and the following was obtained: was the sterility of the package compromised? sterility is damaged.Any hole, puncture or rupture that could compromise sterility? two holes were found on the package before opening the package.Procedure name? are there photos available for review? no." trade name - irgacare " active ingredient(s) triclosan
" dosage form suture/solid/parenteral " strength = 275 ¿g/m.
|